Published in Nature on September 02, 1976
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol (1994) 4.67
Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell (1988) 3.92
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50
Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology (1986) 2.49
Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J Virol (1990) 1.89
Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants. Virology (1990) 1.58
Sequence analysis of fibroblast growth factor receptor 2 ( FGFR2 ) in Japanese patients with craniosynostosis. J Craniofac Surg (2001) 1.47
Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules. Virology (1981) 1.39
Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol (1991) 1.39
Analysis of the hemagglutinin glycoprotein from mutants of vaccinia virus that accumulates on the nuclear envelope. Cell (1983) 1.36
Cloning and characterization of the gene encoding the major protein of the A-type inclusion body of cowpox virus. J Gen Virol (1988) 1.31
On the molecular organization, diversity and functions of desmosomal proteins. Ciba Found Symp (1987) 1.31
Functional comparison of transactivation by human retrovirus rev and rex genes. J Virol (1990) 1.27
Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J Gen Virol (1992) 1.22
Development of heat-stable recombinant rinderpest vaccine. Arch Virol (1989) 1.22
Isolation of the non-glycosylated proteins of desmosomes and immunolocalization of a third plaque protein: desmoplakin III. Proc Natl Acad Sci U S A (1985) 1.17
Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease. J Virol (1988) 1.14
Involvement of human CRM1 (exportin 1) in the export and multimerization of the Rex protein of human T-cell leukemia virus type 1. J Virol (1998) 1.13
Detection and delineation of CXCR-4 (fusin) as an entry and fusion cofactor for T-tropic [correction of T cell-tropic] HIV-1 by three different monoclonal antibodies. J Immunol (1998) 1.12
Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol (1992) 1.10
Simple deep hypothermia for open-heart surgery. J Cardiovasc Surg (Torino) (1979) 1.08
CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry. J Exp Med (1997) 1.07
Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus. J Gen Virol (1991) 1.06
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection. J Virol (1999) 1.04
Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen. Int J Cancer (1991) 1.04
Biogenesis of vaccinia: molecular basis for the hemagglutination-negative phenotype of the IHD-W strain. Virology (1982) 1.01
Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J Virol (1994) 1.00
Structure of the alkali-insoluble skeletal glucan of Lentinus edodes. J Biochem (1981) 1.00
Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions. J Virol (1999) 0.96
Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I). Int J Cancer (1990) 0.95
The function of the vaccinia hemagglutinin in the proteolytic activation of infectivity. Virology (1990) 0.95
Rat CRM1 is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells. J Virol (2001) 0.94
Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett (1998) 0.93
On the water-soluble heterogalactan from the fruit bodies of Lentinus edodes. Carbohydr Res (1975) 0.92
[Mammalian glycosidases. IV. Characterization of alpha-D-mannosidase, alpha-D-glucosidase and beta-D-galactosidase and other various glycosidase activities in organs of rabbits and cats]. Seikagaku (1970) 0.92
Mechanism of virus occlusion into A-type inclusion during poxvirus infection. Virology (1977) 0.91
Comparison of beta-glucan structures in a cell wall mutant of Saccharomyces cerevisiae and the wild type. J Biochem (1985) 0.90
Variants of vaccinia virus hemagglutinin altered in intracellular transport. Mol Cell Biol (1986) 0.89
Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells. J Immunol (1990) 0.89
Cytotoxic T cell response and expression of the target antigen in HTLV-I infection. Leukemia (1994) 0.88
Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region. Virology (2000) 0.87
Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene. J Gen Virol (1997) 0.87
Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas. Int J Gynecol Cancer (2006) 0.87
[Mammalian glycosidases. 2. Ph-dependence and heat tolerance of alpha-mannosidase alpha-glucosidase and alpha-galactosidase activities of the extracts of the various organs of rats and rabbits]. Seikagaku (1969) 0.87
Angiotensin II-induced myocardial damage with a special reference to low cardiac output syndrome. Jpn Heart J (1983) 0.87
Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens. J Immunol (1989) 0.87
In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn J Cancer Res (1995) 0.86
Increased expression in vivo and in vitro of foreign genes directed by A-type inclusion body hybrid promoters in recombinant vaccinia viruses. J Virol (1991) 0.85
Acute changes in plasma levels of hepatocyte growth factor during low-density lipoprotein apheresis. Ther Apher (2001) 0.84
Vaccinia virus hemagglutinin. Subcell Biochem (1989) 0.84
Constructions of vaccinia virus A-type inclusion body protein, tandemly repeated mutant 7.5 kDa protein, and hemagglutinin gene promoters support high levels of expression. Arch Virol (1994) 0.84
Characterization of antibody and cytotoxic T lymphocyte responses to human influenza virus H3 haemagglutinin expressed from the haemagglutinin locus of vaccinia virus. J Gen Virol (1990) 0.83
Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer. Int J Gynecol Cancer (2006) 0.82
An antigenic structure of the trans-activator protein encoded by human T-cell leukemia virus type-I (HTLV-I), as defined by a panel of monoclonal antibodies. AIDS Res Hum Retroviruses (1992) 0.82
Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I. Int J Cancer (1995) 0.81
Two distinct pathways for intronless mRNA expression: one related, the other unrelated to human immunodeficiency virus Rev and human T cell leukemia virus type I Rex functions. Biol Signals (1997) 0.81
Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. J Clin Invest (1994) 0.81
Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus. J Clin Lab Anal (1993) 0.80
Ultrastructural and biochemical identification of Con A receptors in the desmosome. J Cell Biochem (1982) 0.80
Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system. J Immunol (1991) 0.80
[A case of Bence Jones protein kappa type myeloma with adult Fanconi syndrome (author's transl)]. Rinsho Ketsueki (1978) 0.80
Some factors which influence prognosis after surgery for advanced gastric cancer. Ann Surg (1968) 0.80
Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus. Vaccine (1988) 0.79
Anti-annexin A5 antibodies in reproductive failures in relation to antiphospholipid antibodies and phosphatidylserine. Am J Reprod Immunol (2003) 0.78
Demonstration of desmosomal antigens by electron microscopy using cryofixed and cryosubstituted skin with silver-enhanced gold probe. J Histochem Cytochem (1994) 0.78
Biological and immunological characterization of influenza virus haemagglutinin expressed from the haemagglutinin locus of vaccinia virus. J Gen Virol (1990) 0.78
Transcriptional regulation of the vimentin-encoding gene in mouse myeloid leukemia M1 cells. Gene (1995) 0.78
Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice. Virology (1996) 0.77
A cellular protein which is coprecipitated with HTLV-I rex protein in the presence of the target mRNA. Oncogene (1994) 0.77
Intracellular processing and immunogenicity of the envelope proteins of human T-cell leukemia virus type I that are expressed from recombinant vaccinia viruses. Virus Genes (1990) 0.77
Inhibitory mechanisms of insulin secretion associated with hypothermic open-heart surgery. Jpn J Surg (1981) 0.77
Study on peripheral circulation using 131-I-macroaggregated serum albumin. Tohoku J Exp Med (1970) 0.77
Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis. Hypertens Res (2001) 0.77
Choledochal cyst demonstrated by I 131 rose bengal scanning. Report of a case. Am J Roentgenol Radium Ther Nucl Med (1972) 0.76
Role of adrenergic receptor systems in canine left ventricular hypertrophy. J Mol Cell Cardiol (1989) 0.76
[Changes of serum electrolyte levels during open heart surgery with simple profound hypothermia--relationship between transient hypokalemia and metabolic acidosis]. Kyobu Geka (1973) 0.75
Mutant of Escherichia coli that instantaneously loses the ability to adsorb lambda bacteriophage upon exposure to high temperature. J Bacteriol (1976) 0.75
Studies on lipid and carbohydrate metabolism during surface-induced deep hypothermia with circulatory arrest for open-heart surgery. Jpn J Surg (1977) 0.75
[Marfan's syndrome with ascending aortic aneurysm and aortic valve insufficiency - autofluoroscopic diagnosis]. Rinsho Hoshasen (1976) 0.75
Rare variants of Hodgkin's disease of the thymus: report of two cases and proposal for effective clinical management. Jpn J Surg (1986) 0.75
[Studies on priming fluid and transfusion for open heart surgery undergoing cardiopulmonary bypass in the aspects of carbohydrate metabolism (author's transl)]. Kyobu Geka (1977) 0.75
The role of the liver in the changes of acid-base balance and plasma lipids during surface-induced deep hypothermia. Jpn J Surg (1977) 0.75
Experimental studies on myocardial metabolism of carbohydrates and lipids in surface-induced deep hypothermia. Recent Adv Stud Cardiac Struct Metab (1978) 0.75
[Development of a vaccine for adult T-cell leukemia]. Nihon Rinsho (1986) 0.75
Induction of ovulation by a new ovulation-inducing agent, copper N-succinyl glucosamate. J Jpn Obstet Gynecol Soc (1965) 0.75
[A case of aortic regurgitation secondary to chronic aortic retrograde dissection (DeBakey type II) (author's transl)]. Kyobu Geka (1978) 0.75
[Changes of serum digitoxin levels in open heart surgery--comparison between cardiopulmonary bypass and surface-cooling (simple) hypothermia]. Nihon Kyobu Geka Gakkai Zasshi (1977) 0.75
[Application of computed radiography for the diagnosis of chest diseases]. Kokyu To Junkan (1988) 0.75
[Metabolic role of the lung in cardiopulmonary bypass for open-heart surgery--changes of plasma serotonin and platelet (author's transl)]. Nihon Kyobu Geka Gakkai Zasshi (1979) 0.75
[Molecular biology of vaccinia virus and development of a new type of vaccine]. Uirusu (1986) 0.75
[Successful surgical treatment of congenital mitral stenosis with ventricular septal defect and severe pulmonary hypertension. A case report (author's transl)]. Nihon Kyobu Geka Gakkai Zasshi (1978) 0.75
A model experiment to develop a high resolving power analysis of immunoelectron microscopy. J Electron Microsc (Tokyo) (1987) 0.75
[Metabolic role of the lung in surface-induced deep hypothermia for open-heart surgery--changes of serum serotonin and platelet (author's transl)]. Nihon Kyobu Geka Gakkai Zasshi (1979) 0.75
[Colorectal cancer and synchronous adenomatous or malignant polyps--factors influencing its incidence]. Gan No Rinsho (1987) 0.75
Experimental studies on myocardial metabolism of carbohydrate and lipid in surface-induced deep hypothermia. Jpn Circ J (1977) 0.75
[Clinical and experimental studies on the change of plasma lipids during open heart surgery undergoing surface induced deep hypothermia (author's transl)]. Nihon Kyobu Geka Gakkai Zasshi (1977) 0.75